SPL 1.60% 9.6¢ starpharma holdings limited

Ann: Positive final DEP irinotecan Phase 2 clinical trial results, page-13

  1. 15,515 Posts.
    lightbulb Created with Sketch. 5588
    Here We Go finally results that can be partnered with big Pharma for big bucks


    Not what the new CEO Cheryl said in the Webinar @thrasher .... but hey don't take my word for it - here's the link to the Webinar from the Starpharma website ....she clearly states big pharma aren't interested in our DEP drugs at this stage so hardly a 'game changer' today on the back of these results ?


    https://starpharma.com/news/story/investor-webinar-starpharma-business-update-22-may-2024
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.6¢
Change
0.002(1.60%)
Mkt cap ! $39.38M
Open High Low Value Volume
9.4¢ 9.6¢ 9.4¢ $32.09K 339.3K

Buyers (Bids)

No. Vol. Price($)
1 3699 9.5¢
 

Sellers (Offers)

Price($) Vol. No.
9.8¢ 65000 1
View Market Depth
Last trade - 13.54pm 06/08/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.